CVS Health Corporation

NYSE:CVS

Medical - Healthcare Plans

Healthcare
$81.35 -0.59%

-$0.59 today

Market cap
$104.08B
Beta
0.62
P/E (TTM)
42.8
EPS (TTM)
$2.30
Dividend yield
2.70%
52W Low $58.50High $102.77

Volume 17.19M

Average 8.19M

CVS Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

CVS Health CorporationNYSE: CVS

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables growth accelerates

Q2 FY2026 accounts payables of $1.44B rose 76.3% year over year, ahead of the -80.8% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -3.3% a year.

Context

  • Accounts payables amounted to 1.0% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +76.3% holds above the trailing-twelve-month pace of -80.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.44B+355.3% QoQ
Last fiscal yearDec 2025
$3.86B+65.1% YoY
LTMJun 2026
$947M-80.8% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+76.3%——
1 year+65.1%——
3-year CAGR-3.3%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
3.86B USD
Year-over-year change
+65.1%
4-year CAGR
+7.4%

Accounts Payables vs competitors

How CVS compares with its peers on the latest reported figures

  • CVS's LTM Jun 2026 accounts payables of $947M is the 5th largest of the 9 companies compared; the peer median is $34.13M.
  • Its year-over-year change of -80.8% is the 6th highest of 9, against a peer median of +4.6%.
  • Accounts payables amounts to 0.2% of revenue for CVS, versus a peer median of 0.5%.
CVS Competitors Peer median
Accounts Payables for CVS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CNCCentene CorporationLTM Jun 2026$6.37B +332.8%—3.3%
UNHUnitedHealth Group IncorporatedLTM Sep 2026$6.18B -183.6%—1.4%
CICigna CorporationLTM Sep 2026$3.55B +304.3%+17.3%1.2%
ELVElevance Health Inc.LTM Sep 2026$1.02B -400.6%—0.5%
CVSCVS Health CorporationLTM Jun 2026$947M -80.8%-3.3%0.2%
HUMHumana Inc.LTM Sep 2026$121M -88.3%—0.1%
OSCROscar Health, Inc.LTM Jun 2026$74.49M -60.0%-15.7%0.5%
MOHMolina Healthcare, Inc.LTM Sep 2026$62M +231.9%—0.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$6.26M +69.2%—0.1%
Peer median (excluding CVS) $34.13M+4.6%+0.8%0.5%

Competitors are the stored peer set for CVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income7.99B4.33B8.37B4.59B1.73B
Depreciation & Amortization4.49B4.22B4.37B4.6B4.61B
Deferred Income Tax(402M)(2.03B)(676M)(572M)102M
Stock-Based Compensation484M447M588M540M535M
Change in Working Capital3.86B6.82B15M109M(1.47B)
Accounts Receivables(2.7B)(2.97B)(6.26B)(1.3B)(3.5B)
Inventory735M(1.44B)1.23B(102M)(1.27B)
Accounts Payables2.9B4.26B3.62B2.34B3.86B
Other Working Capital2.93B6.96B1.42B(823M)(564M)
Other Non-Cash Items1.85B2.39B765M(153M)5.14B
Operating Cash Flow18.27B16.18B13.43B9.11B10.64B
Capital Expenditures(2.52B)(2.73B)(3.03B)(2.78B)(2.83B)
Acquisitions (Net)(146M)(1.39B)(16.61B)(95M)(436M)
Purchases of Investments(9.96B)(7.75B)(9.04B)(15.19B)(15.01B)
Sales of Investments7.25B6.73B7.73B10.35B12.38B
Other Investing Activities122M85M68M101M26M
Investing Cash Flow(5.26B)(5.05B)(20.89B)(7.61B)(5.87B)
Debt Repayment(9.27B)(4.21B)7.93B5.06B(3.9B)
Common Stock Issued0000394M
Common Stock Repurchased0(3.5B)(2.01B)(3.02B)0
Dividends Paid(2.63B)(2.91B)(3.13B)(3.37B)(3.4B)
Other Financing Activities536M102M(105M)202M1.96B
Financing Cash Flow(11.36B)(10.52B)2.68B(1.14B)(4.94B)
Effect of Forex Changes00000
Net Change in Cash1.65B614M(4.78B)359M(172M)
Free Cash Flow15.75B13.45B10.4B6.33B7.81B

CVS Health Corporation

NYSE:CVS

Intrinsic Alpha fair value

Locked

Current Price

$81.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.